Parasellar spaces remain particularly singular, comprising the most important neurovascular structures such as the internal carotid artery and optic, oculomotor, and trigeminal nerves. Meningiomas are one of the most frequent tumors arising from parasellar spaces. In this location, meningiomas remain mostly benign tumors with WHO grade I and a meningothelial subtype. Progestin intake should be investigated and leads mostly to conservative strategies. In the case of benign nonsymptomatic tumors, observation should be proposed. Tumor growth will lead to the proposition of surgery or radiosurgery. In the case of an uncertain diagnosis and an aggressive pattern, a precise diagnosis is required. For cavernous sinus and Meckel’s cave lesions, complete removal is rarely considered, leading to the proposition of an endoscopic endonasal or transcranial biopsy. Optic nerve decompression could also be proposed via these approaches. A case-by-case discussion about the best approach is recommended. A transcranial approach remains necessary for tumor removal in most cases. Vascular injury could lead to severe complications. Cerebrospinal fluid leakage, meningitis, venous sacrifice, visual impairment, and cranial nerve palsies are more frequent complications. Pituitary dysfunctions are rare in preoperative assessment and in postoperative follow-up but should be assessed in the case of meningiomas located close to the pituitary axis. Long-term follow-up is required given the frequent incomplete tumor removal and the risk of delayed recurrence. Radiosurgery is relevant for small and well-limited meningiomas or intra-cavernous sinus postoperative residue, whereas radiation therapy and proton beam therapy are indicated for large, extended, nonoperable meningiomas. The place of the peptide receptor radionuclide therapyneeds to be defined. Targeted therapy should be considered in rare, recurrent, and aggressive parasellar meningiomas.

1.
Rhoton
AL
 Jr
.
The sellar region
.
Neurosurgery
.
2002
Oct
;
51
(
4
Suppl
):
S335
74
.
[PubMed]
0148-396X
2.
Yasuda
A
,
Campero
A
,
Martins
C
,
Rhoton
AL
 Jr
,
de Oliveira
E
,
Ribas
GC
.
Microsurgical anatomy and approaches to the cavernous sinus
.
Neurosurgery
.
2008
Jun
;
62
(
6
Suppl 3
):
1240
63
.
[PubMed]
0148-396X
3.
Sabancı
PA
,
Batay
F
,
Civelek
E
,
Al Mefty
O
,
Husain
M
,
Abdulrauf
SI
, et al.
Meckel’s cave
.
World Neurosurg
.
2011
Sep-Oct
;
76
(
3-4
):
335
41
.
[PubMed]
1878-8750
4.
Parkinson
D
.
Lateral sellar compartment O.T. (cavernous sinus): history, anatomy, terminology
.
Anat Rec
.
1998
Aug
;
251
(
4
):
486
90
.
[PubMed]
0003-276X
5.
Taptas
JN
.
The so-called cavernous sinus: a review of the controversy and its implications for neurosurgeons
.
Neurosurgery
.
1982
Nov
;
11
(
5
):
712
7
.
[PubMed]
0148-396X
6.
Taptas
JN
.
[The parasellar osteo-dural chamber and the vascular and neural elements that traverse it. An anatomical concept that would replace the cavernous sinus of classical anatomy]
.
Neurochirurgie
.
1990
;
36
(
4
):
201
8
.
[PubMed]
0028-3770
7.
Umansky
F
,
Nathan
H
.
The lateral wall of the cavernous sinus. With special reference to the nerves related to it
.
J Neurosurg
.
1982
Feb
;
56
(
2
):
228
34
.
[PubMed]
0022-3085
8.
Umansky
F
,
Valarezo
A
,
Elidan
J
.
The superior wall of the cavernous sinus: a microanatomical study
.
J Neurosurg
.
1994
Dec
;
81
(
6
):
914
20
.
[PubMed]
0022-3085
9.
Kehrli
P
,
Maillot
C
,
Wolff
MJ
.
The venous system of the lateral sellar compartment (cavernous sinus): an histological and embryological study
.
Neurol Res
.
1996
Oct
;
18
(
5
):
387
93
.
[PubMed]
0161-6412
10.
Kehrli
P
,
Ali
M
,
Reis
M
 Jr
,
Maillot
C
,
Dietemann
JL
,
Dujovny
M
, et al.
Anatomy and embryology of the lateral sellar compartment (cavernous sinus) medial wall
.
Neurol Res
.
1998
Oct
;
20
(
7
):
585
92
.
[PubMed]
0161-6412
11.
Dietemann
JL
,
Kehrli
P
,
Maillot
C
,
Diniz
R
,
Reis
M
 Jr
,
Neugroschl
C
, et al.
Is there a dural wall between the cavernous sinus and the pituitary fossa? Anatomical and MRI findings
.
Neuroradiology
.
1998
Oct
;
40
(
10
):
627
30
.
[PubMed]
0028-3940
12.
Parkinson
D
.
Surgical anatomy of the lateral sellar compartment (cavernous sinus)
.
Clin Neurosurg
.
1990
;
36
:
219
39
.
[PubMed]
0069-4827
13.
Kawase
T
,
van Loveren
H
,
Keller
JT
,
Tew
JM
.
Meningeal architecture of the cavernous sinus: clinical and surgical implications
.
Neurosurgery
.
1996
Sep
;
39
(
3
):
527
34
.
[PubMed]
0148-396X
14.
Dolenc
VV
.
Surgery of vascular lesions of the cavernous sinus
.
Clin Neurosurg
.
1990
;
36
:
240
55
.
[PubMed]
0069-4827
15.
Kobayashi
M
,
Kawase
T
.
[Interdural approach for cavernous sinus lesions]
.
No Shinkei Geka
.
2008
Dec
;
36
(
12
):
1081
90
.
[PubMed]
0301-2603
16.
FitzPatrick
M
,
Tartaglino
LM
,
Hollander
MD
,
Zimmerman
RA
,
Flanders
AE
.
Imaging of sellar and parasellar pathology
.
[x.]
.
Radiol Clin North Am
.
1999
Jan
;
37
(
1
):
101
21
.
[PubMed]
0033-8389
17.
Al-Mefty
O
.
Clinoidal meningiomas
.
J Neurosurg
.
1990
Dec
;
73
(
6
):
840
9
.
[PubMed]
0022-3085
18.
Kawase
T
,
Shiobara
R
,
Ohira
T
,
Toya
S
.
Developmental patterns and characteristic symptoms of petroclival meningiomas
.
Neurol Med Chir (Tokyo)
.
1996
Jan
;
36
(
1
):
1
6
.
[PubMed]
0470-8105
19.
Mohme
M
,
Emami
P
,
Regelsberger
J
,
Matschke
J
,
Lamszus
K
,
Westphal
M
, et al.
Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype
.
World Neurosurg
.
2016
Aug
;
92
:
418
25
.
[PubMed]
1878-8750
20.
Mortazavi
MM
,
Brito da Silva
H
,
Ferreira
M
 Jr
,
Barber
JK
,
Pridgeon
JS
,
Sekhar
LN
.
Planum Sphenoidale and Tuberculum Sellae Meningiomas: Operative Nuances of a Modern Surgical Technique with Outcome and Proposal of a New Classification System
.
World Neurosurg
.
2016
Feb
;
86
:
270
86
.
[PubMed]
1878-8750
21.
Magill
ST
,
Morshed
RA
,
Lucas
CG
,
Aghi
MK
,
Theodosopoulos
PV
,
Berger
MS
, et al.
Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach
.
Neurosurg Focus
.
2018
Apr
;
44
(
4
):
E9
.
[PubMed]
1092-0684
22.
Kinjo
T
,
al-Mefty
O
,
Ciric
I
.
Diaphragma sellae meningiomas
.
Neurosurgery
.
1995
Jun
;
36
(
6
):
1082
92
.
[PubMed]
0148-396X
23.
Maiuri
F
,
Mariniello
G
,
Guadagno
E
,
Barbato
M
,
Corvino
S
,
Del Basso De Caro
M
.
WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma
.
Acta Neurochir (Wien)
.
2019
Dec
;
161
(
12
):
2553
61
.
[PubMed]
0001-6268
24.
Graillon
T
,
Romano
D
,
Defilles
C
,
Saveanu
A
,
Mohamed
A
,
Figarella-Branger
D
, et al.
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
.
J Neurosurg
.
2016
Dec
;
•••
:
1
10
.
[PubMed]
0022-3085
25.
Nishio
S
,
Morioka
T
,
Suzuki
S
,
Hirano
K
,
Fukui
M
.
Secretory meningioma: clinicopathologic features of eight cases
.
J Clin Neurosci
.
2001
Jul
;
8
(
4
):
335
9
.
[PubMed]
0967-5868
26.
Tao
X
,
Dong
J
,
Hou
Z
,
Hao
S
,
Zhang
J
,
Wu
Z
, et al.
Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas
.
World Neurosurg
.
2018
Mar
;
111
:
e880
7
.
[PubMed]
1878-8750
27.
Li
P
,
Yang
Z
,
Wang
Z
,
Zhou
Q
,
Li
S
,
Wang
X
, et al.
Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution
.
Acta Neurochir (Wien)
.
2016
Jan
;
158
(
1
):
67
76
.
[PubMed]
0001-6268
28.
Zhang
H
,
Ma
L
,
Wang
YB
,
Shu
C
,
Kuang
W
,
Huang
YA
, et al.
Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence. World Neurosurg.
2017
Jan;97:693-700 e11.
29.
Suppiah
S
,
Nassiri
F
,
Bi
WL
,
Dunn
IF
,
Hanemann
CO
,
Horbinski
CM
, et al.
Molecular and translational advances in meningiomas.
Neuro Oncol.
2019
Jan 14;21(Supplement_1):i4-i17.
30.
Bi
WL
,
Abedalthagafi
M
,
Horowitz
P
,
Agarwalla
PK
,
Mei
Y
,
Aizer
AA
, et al.
Genomic landscape of intracranial meningiomas
.
J Neurosurg
.
2016
Sep
;
125
(
3
):
525
35
.
[PubMed]
0022-3085
31.
Clark
VE
,
Erson-Omay
EZ
,
Serin
A
,
Yin
J
,
Cotney
J
,
Ozduman
K
, et al.
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO
.
Science
.
2013
Mar
;
339
(
6123
):
1077
80
.
[PubMed]
0036-8075
32.
Clark
VE
,
Harmancı
AS
,
Bai
H
,
Youngblood
MW
,
Lee
TI
,
Baranoski
JF
, et al.
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
.
Nat Genet
.
2016
Oct
;
48
(
10
):
1253
9
.
[PubMed]
1061-4036
33.
Sahm
F
,
Schrimpf
D
,
Stichel
D
,
Jones
DT
,
Hielscher
T
,
Schefzyk
S
, et al.
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
.
Lancet Oncol
.
2017
May
;
18
(
5
):
682
94
.
[PubMed]
1470-2045
34.
Katz
LM
,
Hielscher
T
,
Liechty
B
,
Silverman
J
,
Zagzag
D
,
Sen
R
, et al.
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
.
Acta Neuropathol
.
2018
Jun
;
135
(
6
):
955
63
.
[PubMed]
0001-6322
35.
Sen
C
,
Hague
K
.
Meningiomas involving the cavernous sinus: histological factors affecting the degree of resection
.
J Neurosurg
.
1997
Oct
;
87
(
4
):
535
43
.
[PubMed]
0022-3085
36.
O’Sullivan
MG
,
van Loveren
HR
,
Tew
JM
 Jr
.
The surgical resectability of meningiomas of the cavernous sinus
.
Neurosurgery
.
1997
Feb
;
40
(
2
):
238
44
.
[PubMed]
0148-396X
37.
Larson
JJ
,
van Loveren
HR
,
Balko
MG
,
Tew
JM
 Jr
.
Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas
.
J Neurosurg
.
1995
Oct
;
83
(
4
):
596
9
.
[PubMed]
0022-3085
38.
Ivanidze
J
,
Roytman
M
,
Lin
E
,
Magge
RS
,
Pisapia
DJ
,
Liechty
B
, et al.
Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas
.
J Neuroimaging
.
2019
Sep
;
29
(
5
):
650
6
.
[PubMed]
1051-2284
39.
Galldiks
N
,
Albert
NL
,
Sommerauer
M
,
Grosu
AL
,
Ganswindt
U
,
Law
I
, et al.
PET imaging in patients with meningioma-report of the RANO/PET Group
.
Neuro-oncol
.
2017
Nov
;
19
(
12
):
1576
87
.
[PubMed]
1522-8517
40.
Unterrainer
M
,
Ilhan
H
,
Vettermann
F
,
Cyran
CC
,
Tonn
JC
,
Niyazi
M
, et al.
Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT
.
Clin Nucl Med
.
2019
Mar
;
44
(
3
):
227
8
.
[PubMed]
0363-9762
41.
Unterrainer
M
,
Ruf
V
,
Ilhan
H
,
Vettermann
FJ
,
Cyran
CC
,
Niyazi
M
, et al.
68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases
.
Clin Nucl Med
.
2019
May
;
44
(
5
):
412
3
.
[PubMed]
0363-9762
42.
Villanueva-Meyer
JE
,
Magill
ST
,
Lee
JC
,
Umetsu
SE
,
Flavell
RR
.
Detection of Metastatic Meningioma to the Liver Using 68Ga-DOTA-Octreotate PET/CT
.
Clin Nucl Med
.
2018
Sep
;
43
(
9
):
e338
40
.
[PubMed]
0363-9762
43.
Jacob
M
,
Raverot
G
,
Jouanneau
E
,
Borson-Chazot
F
,
Perrin
G
,
Rabilloud
M
, et al.
Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography.
Am J Ophthalmol.
2009
Jan;147(1):64-70 e2.
44.
Danesh-Meyer
HV
,
Wong
A
,
Papchenko
T
,
Matheos
K
,
Stylli
S
,
Nichols
A
, et al.
Optical coherence tomography predicts visual outcome for pituitary tumors
.
J Clin Neurosci
.
2015
Jul
;
22
(
7
):
1098
104
.
[PubMed]
0967-5868
45.
Garcia
T
,
Sanchez
S
,
Litré
CF
,
Radoi
C
,
Delemer
B
,
Rousseaux
P
, et al.
Prognostic value of retinal nerve fiber layer thickness for postoperative peripheral visual field recovery in optic chiasm compression
.
J Neurosurg
.
2014
Jul
;
121
(
1
):
165
9
.
[PubMed]
0022-3085
46.
Blanch
RJ
,
Micieli
JA
,
Oyesiku
NM
,
Newman
NJ
,
Biousse
V
.
Optical coherence tomography retinal ganglion cell complex analysis for the detection of early chiasmal compression
.
Pituitary
.
2018
Oct
;
21
(
5
):
515
23
.
[PubMed]
1386-341X
47.
Tieger
MG
,
Hedges
TR
 3rd
,
Ho
J
,
Erlich-Malona
NK
,
Vuong
LN
,
Athappilly
GK
, et al.
Ganglion Cell Complex Loss in Chiasmal Compression by Brain Tumors
.
J Neuroophthalmol
.
2017
Mar
;
37
(
1
):
7
12
.
[PubMed]
1070-8022
48.
Jacquesson
T
,
Frindel
C
,
Kocevar
G
,
Berhouma
M
,
Jouanneau
E
,
Attyé
A
, et al.
Overcoming Challenges of Cranial Nerve Tractography: A Targeted Review
.
Neurosurgery
.
2019
Feb
;
84
(
2
):
313
25
.
[PubMed]
0148-396X
49.
Fahlbusch
R
,
Schott
W
.
Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes
.
J Neurosurg
.
2002
Feb
;
96
(
2
):
235
43
.
[PubMed]
0022-3085
50.
Giammattei
L
,
Starnoni
D
,
Cossu
G
,
Bruneau
M
,
Cavallo
LM
,
Cappabianca
P
, et al.
Surgical management of Tuberculum sellae Meningiomas: Myths, facts, and controversies. Acta Neurochir (Wien).
2019
Dec 13.
51.
DeMonte
F
,
Harrison
RL
,
al-Mefty
O
.
Dislocation of the pituitary gland by sphenocavernous meningiomas
.
Surg Neurol
.
1997
Jan
;
47
(
1
):
43
6
.
[PubMed]
0090-3019
52.
Komotar
RJ
,
Starke
RM
,
Raper
DM
,
Anand
VK
,
Schwartz
TH
.
Endoscopic endonasal versus open transcranial resection of anterior midline skull base meningiomas
.
World Neurosurg
.
2012
May-Jun
;
77
(
5-6
):
713
24
.
[PubMed]
1878-8750
53.
Bassiouni
H
,
Asgari
S
,
Stolke
D.
Tuberculum sellae meningiomas: functional outcome in a consecutive series treated microsurgically.
Surg Neurol.
2006
Jul;66(1):37-44; discussion -5.
54.
Ciric
I
,
Rosenblatt
S
.
Suprasellar meningiomas
.
Neurosurgery
.
2001
Dec
;
49
(
6
):
1372
7
.
[PubMed]
0148-396X
55.
Fujio
S
,
Hirano
H
,
Yamashita
M
,
Usui
S
,
Kinoshita
Y
,
Tominaga
A
, et al.
Preoperative and Postoperative Pituitary Function in Patients with Tuberculum Sellae Meningioma -Based on Pituitary Provocation Tests
.
Neurol Med Chir (Tokyo)
.
2017
Oct
;
57
(
10
):
548
56
.
[PubMed]
0470-8105
56.
Jallo
GI
,
Benjamin
V
.
Tuberculum sellae meningiomas: microsurgical anatomy and surgical technique
.
Neurosurgery
.
2002
Dec
;
51
(
6
):
1432
9
.
[PubMed]
0148-396X
57.
Messerer
M
,
Dubourg
J
,
Saint-Pierre
G
,
Jouanneau
E
,
Sindou
M
.
Percutaneous biopsy of lesions in the cavernous sinus region through the foramen ovale: diagnostic accuracy and limits in 50 patients
.
J Neurosurg
.
2012
Feb
;
116
(
2
):
390
8
.
[PubMed]
0022-3085
58.
Jouanneau
E
,
Simon
E
,
Jacquesson
T
,
Sindou
M
,
Tringali
S
,
Messerer
M
, et al.
The endoscopic endonasal approach to the Meckel’s cave tumors: surgical technique and indications
.
World Neurosurg
.
2014
Dec
;
82
(
6
Suppl
):
S155
61
.
[PubMed]
1878-8750
59.
Graillon
T
,
Fuentes
S
,
Metellus
P
,
Adetchessi
T
,
Gras
R
,
Dufour
H
.
Limited endoscopic transsphenoidal approach for cavernous sinus biopsy: illustration of 3 cases and discussion
.
Neurochirurgie
.
2014
Feb-Apr
;
60
(
1-2
):
42
7
.
[PubMed]
0028-3770
60.
Palejwala
SK
,
Zhao
F
,
Lanker
KC
,
Sivakumar
W
,
Takasumi
Y
,
Griffiths
CF
, et al.
Imaging-Ambiguous Lesions of Meckel’s Cave-Utility of Endoscopic Endonasal Transpterygoid Biopsy
.
World Neurosurg
.
2018
Oct
;
118
:
e346
55
.
[PubMed]
1878-8750
61.
Hardesty
DA
,
Montaser
AS
,
Carrau
RL
,
Prevedello
DM
.
Limits of endoscopic endonasal transpterygoid approach to cavernous sinus and Meckel’s cave
.
J Neurosurg Sci
.
2018
Jun
;
62
(
3
):
332
8
.
[PubMed]
1827-1855
62.
Amelot
A
,
van Effenterre
R
,
Kalamarides
M
,
Cornu
P
,
Boch
AL
.
Natural history of cavernous sinus meningiomas
.
J Neurosurg
.
2018
Mar
;
•••
:
1
8
.
[PubMed]
1933-0693
63.
Pollock
BE
,
Stafford
SL
,
Utter
A
,
Giannini
C
,
Schreiner
SA
.
Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas
.
Int J Radiat Oncol Biol Phys
.
2003
Mar
;
55
(
4
):
1000
5
.
[PubMed]
0360-3016
64.
Abdel-Aziz
KM
,
Froelich
SC
,
Dagnew
E
,
Jean
W
,
Breneman
JC
,
Zuccarello
M
, et al.
Large sphenoid wing meningiomas involving the cavernous sinus: conservative surgical strategies for better functional outcomes
.
Neurosurgery
.
2004
Jun
;
54
(
6
):
1375
83
.
[PubMed]
0148-396X
65.
Giammattei
L
,
Starnoni
D
,
Levivier
M
,
Messerer
M
,
Daniel
RT
.
Surgery for Clinoidal Meningiomas: Case Series and Meta-Analysis of Outcomes and Complications
.
World Neurosurg
.
2019
Sep
;
129
:
e700
17
.
[PubMed]
1878-8750
66.
Lehmberg
J
,
Krieg
SM
,
Mueller
B
,
Meyer
B
.
Impact of anterior clinoidectomy on visual function after resection of meningiomas in and around the optic canal
.
Acta Neurochir (Wien)
.
2013
Jul
;
155
(
7
):
1293
9
.
[PubMed]
0001-6268
67.
Berhouma
M
,
Jacquesson
T
,
Abouaf
L
,
Vighetto
A
,
Jouanneau
E
.
Endoscopic endonasal optic nerve and orbital apex decompression for nontraumatic optic neuropathy: surgical nuances and review of the literature
.
Neurosurg Focus
.
2014
;
37
(
4
):
E19
.
[PubMed]
1092-0684
68.
Caporlingua
A
,
Prior
A
,
Cavagnaro
MJ
,
Winston
G
,
Oliveira
DL
,
Sadwhani
SD
, et al.
The Intracranial and Intracanalicular Optic Nerve as Seen Through Different Surgical Windows: Endoscopic Versus Transcranial
.
World Neurosurg
.
2019
Apr
;
124
:
522
38
.
[PubMed]
1878-8750
69.
Gogela
SL
,
Zimmer
LA
,
Keller
JT
,
Andaluz
N
.
Refining Operative Strategies for Optic Nerve Decompression: A Morphometric Analysis of Transcranial and Endoscopic Endonasal Techniques Using Clinical Parameters
.
Oper Neurosurg (Hagerstown)
.
2018
Mar
;
14
(
3
):
295
302
.
[PubMed]
2332-4252
70.
Couldwell
WT
,
Kan
P
,
Liu
JK
,
Apfelbaum
RI
.
Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical note
.
J Neurosurg
.
2006
Jul
;
105
(
1
):
148
52
.
[PubMed]
0022-3085
71.
Gozal
YM
,
Alzhrani
G
,
Abou-Al-Shaar
H
,
Azab
MA
,
Walsh
MT
,
Couldwell
WT
.
Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients
.
J Neurosurg
.
2019
Feb
;
132
(
2
):
380
7
.
[PubMed]
0022-3085
72.
Lobo
B
,
Zhang
X
,
Barkhoudarian
G
,
Griffiths
CF
,
Kelly
DF
.
Endonasal Endoscopic Management of Parasellar and Cavernous Sinus Meningiomas
.
Neurosurg Clin N Am
.
2015
Jul
;
26
(
3
):
389
401
.
[PubMed]
1042-3680
73.
Sivakumar
W
,
Barkhoudarian
G
,
Lobo
BM
,
Zhang
X
,
Zhao
F
,
Eisenberg
A
, et al.
Strategy and Technique of Endonasal Endoscopic Bony Decompression and Selective Tumor Removal in Symptomatic Skull Base Meningiomas of the Cavernous Sinus and Meckel’s Cave
.
World Neurosurg
.
2019
Nov
;
131
:
e12
22
.
[PubMed]
1878-8750
74.
Akutsu
H
,
Kreutzer
J
,
Fahlbusch
R
,
Buchfelder
M
.
Transsphenoidal decompression of the sellar floor for cavernous sinus meningiomas: experience with 21 patients
.
[discussion]
.
Neurosurgery
.
2009
Jul
;
65
(
1
):
54
62
.
[PubMed]
0148-396X
75.
Almefty
R
,
Dunn
IF
,
Pravdenkova
S
,
Abolfotoh
M
,
Al-Mefty
O
.
True petroclival meningiomas: results of surgical management
.
J Neurosurg
.
2014
Jan
;
120
(
1
):
40
51
.
[PubMed]
0022-3085
76.
Soni
RS
,
Patel
SK
,
Husain
Q
,
Dahodwala
MQ
,
Eloy
JA
,
Liu
JK
.
From above or below: the controversy and historical evolution of tuberculum sellae meningioma resection from open to endoscopic skull base approaches
.
J Clin Neurosci
.
2014
Apr
;
21
(
4
):
559
68
.
[PubMed]
0967-5868
77.
Fatemi
N
,
Dusick
JR
,
de Paiva Neto
MA
,
Malkasian
D
,
Kelly
DF
.
Endonasal versus supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas
.
Neurosurgery
.
2009
May
;
64
(
5
Suppl 2
):
269
84
.
[PubMed]
1524-4040
78.
de Divitiis
E
,
Esposito
F
,
Cappabianca
P
,
Cavallo
LM
,
de Divitiis
O
. Tuberculum sellae meningiomas: high route or low route? A series of 51 consecutive cases. Neurosurgery.
2008
Mar;62(3):556-63; discussion -63.
79.
Mathiesen
T
,
Kihlstrom
L
.
Visual outcome of tuberculum sellae meningiomas after extradural optic nerve decompression.
Neurosurgery.
2006
Sep;59(3):570-6; discussion -6.
80.
Muskens
IS
,
Briceno
V
,
Ouwehand
TL
,
Castlen
JP
,
Gormley
WB
,
Aglio
LS
, et al.
The endoscopic endonasal approach is not superior to the microscopic transcranial approach for anterior skull base meningiomas-a meta-analysis
.
Acta Neurochir (Wien)
.
2018
Jan
;
160
(
1
):
59
75
.
[PubMed]
0001-6268
81.
Mahmoud
M
,
Nader
R
,
Al-Mefty
O
.
Optic canal involvement in tuberculum sellae meningiomas: influence on approach, recurrence, and visual recovery.
Neurosurgery.
2010
Sep;67(3 Suppl Operative):ons108-18; discussion ons18-9.
82.
Turel
MK
,
Tsermoulas
G
,
Reddy
D
,
Andrade-Barazarte
H
,
Zadeh
G
,
Gentili
F
.
Endonasal endoscopic transsphenoidal excision of tuberculum sellae meningiomas: a systematic review
.
J Neurosurg Sci
.
2016
Dec
;
60
(
4
):
463
75
.
[PubMed]
1827-1855
83.
Turel
MK
,
Tsermoulas
G
,
Yassin-Kassab
A
,
Reddy
D
,
Andrade-Barazarte
H
,
Gonen
L
, et al.
Tuberculum sellae meningiomas: a systematic review of transcranial approaches in the endoscopic era
.
J Neurosurg Sci
.
2019
Apr
;
63
(
2
):
200
15
.
[PubMed]
0390-5616
84.
Engelhardt
J
,
Namaki
H
,
Mollier
O
,
Monteil
P
,
Penchet
G
,
Cuny
E
, et al.
Contralateral Transcranial Approach to Tuberculum Sellae Meningiomas: Long-Term Visual Outcomes and Recurrence Rates
.
World Neurosurg
.
2018
Aug
;
116
:
e1066
74
.
[PubMed]
1878-8750
85.
Jang
WY
,
Jung
S
,
Jung
TY
,
Moon
KS
,
Kim
IY
.
The contralateral subfrontal approach can simplify surgery and provide favorable visual outcome in tuberculum sellae meningiomas
.
Neurosurg Rev
.
2012
Oct
;
35
(
4
):
601
7
.
[PubMed]
0344-5607
86.
Wilson
DA
,
Duong
H
,
Teo
C
,
Kelly
DF
.
The supraorbital endoscopic approach for tumors
.
World Neurosurg
.
2014
Dec
;
82
(
6
Suppl
):
S72
80
.
[PubMed]
1878-8750
87.
Simpson
D
.
The recurrence of intracranial meningiomas after surgical treatment
.
J Neurol Neurosurg Psychiatry
.
1957
Feb
;
20
(
1
):
22
39
.
[PubMed]
0022-3050
88.
Taha
AN
,
Erkmen
K
,
Dunn
IF
,
Pravdenkova
S
,
Al-Mefty
O
.
Meningiomas involving the optic canal: pattern of involvement and implications for surgical technique
.
Neurosurg Focus
.
2011
May
;
30
(
5
):
E12
.
[PubMed]
1092-0684
89.
Almefty
R
,
Dunn
IF
,
Aziz-Sultan
MA
,
Al-Mefty
O
.
Delayed Carotid Pseudoaneurysms from Iatrogenic Clival Meningeal Branches Avulsion: Recognition and Proposed Management
.
World Neurosurg
.
2017
Aug
;
104
:
736
44
.
[PubMed]
1878-8750
90.
Lehmberg
J
,
Krieg
SM
,
Meyer
B
.
Anterior clinoidectomy
.
Acta Neurochir (Wien)
.
2014
Feb
;
156
(
2
):
415
9
.
[PubMed]
0001-6268
91.
Hafez
A
,
Nader
R
,
Al-Mefty
O
.
Preservation of the superior petrosal sinus during the petrosal approach
.
J Neurosurg
.
2011
May
;
114
(
5
):
1294
8
.
[PubMed]
0022-3085
92.
Cho
CW
,
Al-Mefty
O
.
Combined petrosal approach to petroclival meningiomas
.
Neurosurgery
.
2002
Sep
;
51
(
3
):
708
16
.
[PubMed]
0148-396X
93.
Goldbrunner
R
,
Minniti
G
,
Preusser
M
,
Jenkinson
MD
,
Sallabanda
K
,
Houdart
E
, et al.
EANO guidelines for the diagnosis and treatment of meningiomas
.
Lancet Oncol
.
2016
Sep
;
17
(
9
):
e383
91
.
[PubMed]
1470-2045
94.
Dusick
JR
,
Fatemi
N
,
Mattozo
C
,
McArthur
D
,
Cohan
P
,
Wang
C
, et al.
Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: rathke’s cleft cysts, craniopharyngiomas, and meningiomas
.
Surg Neurol
.
2008
Nov
;
70
(
5
):
482
90
.
[PubMed]
0090-3019
95.
Karsy
M
,
Raheja
A
,
Eli
I
,
Guan
J
,
Couldwell
WT
.
Clinical Outcomes with Transcranial Resection of the Tuberculum Sellae Meningioma
.
World Neurosurg
.
2017
Dec
;
108
:
748
55
.
[PubMed]
1878-8750
96.
Wilk
A
,
Zielinski
G
,
Witek
P
,
Koziarski
A
.
Outcome Assessment After Surgical Treatment of Tuberculum Sellae Meningiomas- A Preliminary Report
.
Turk Neurosurg
.
2016
;
26
(
6
):
824
32
.
[PubMed]
1019-5149
97.
Sindou
M
,
Wydh
E
,
Jouanneau
E
,
Nebbal
M
,
Lieutaud
T
.
Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone
.
J Neurosurg
.
2007
Nov
;
107
(
5
):
937
44
.
[PubMed]
0022-3085
98.
Soldà
F
,
Wharram
B
,
De Ieso
PB
,
Bonner
J
,
Ashley
S
,
Brada
M
.
Long-term efficacy of fractionated radiotherapy for benign meningiomas
.
Radiother Oncol
.
2013
Nov
;
109
(
2
):
330
4
.
[PubMed]
0167-8140
99.
Fokas
E
,
Henzel
M
,
Surber
G
,
Hamm
K
,
Engenhart-Cabillic
R
.
Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients
.
Int J Radiat Oncol Biol Phys
.
2014
Jul
;
89
(
3
):
569
75
.
[PubMed]
0360-3016
100.
Correa
SF
,
Marta
GN
,
Teixeira
MJ
.
Neurosymptomatic carvenous sinus meningioma: a 15-years experience with fractionated stereotactic radiotherapy and radiosurgery
.
Radiat Oncol
.
2014
Jan
;
9
(
1
):
27
.
[PubMed]
1748-717X
101.
Metellus
P
,
Regis
J
,
Muracciole
X
,
Fuentes
S
,
Dufour
H
,
Nanni
I
, et al.
Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy.
Neurosurgery.
2005
Nov;57(5):873-86; discussion -86.
102.
Leroy
HA
,
Tuleasca
C
,
Reyns
N
,
Levivier
M
.
Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis
.
Acta Neurochir (Wien)
.
2018
Dec
;
160
(
12
):
2367
78
.
[PubMed]
0001-6268
103.
Milker-Zabel
S
,
Zabel-du Bois
A
,
Huber
P
,
Schlegel
W
,
Debus
J
.
Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature
.
Strahlenther Onkol
.
2006
Nov
;
182
(
11
):
635
40
.
[PubMed]
0179-7158
104.
Marchetti
M
,
Bianchi
S
,
Pinzi
V
,
Tramacere
I
,
Fumagalli
ML
,
Milanesi
IM
, et al.
Multisession Radiosurgery for Sellar and Parasellar Benign Meningiomas: Long-term Tumor Growth Control and Visual Outcome
.
Neurosurgery
.
2016
May
;
78
(
5
):
638
46
.
[PubMed]
0148-396X
105.
Roche
PH
,
Régis
J
,
Dufour
H
,
Fournier
HD
,
Delsanti
C
,
Pellet
W
, et al.
Gamma knife radiosurgery in the management of cavernous sinus meningiomas
.
J Neurosurg
.
2000
Dec
;
93
Suppl 3
:
68
73
.
[PubMed]
0022-3085
106.
Sheehan
JP
,
Starke
RM
,
Kano
H
,
Kaufmann
AM
,
Mathieu
D
,
Zeiler
FA
, et al.
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study
.
J Neurosurg
.
2014
Jun
;
120
(
6
):
1268
77
.
[PubMed]
0022-3085
107.
Cohen-Inbar
O
,
Tata
A
,
Moosa
S
,
Lee
CC
,
Sheehan
JP
.
Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation
.
J Neurosurg
.
2018
Feb
;
128
(
2
):
362
72
.
[PubMed]
0022-3085
108.
Lee
CC
,
Trifiletti
DM
,
Sahgal
A
,
DeSalles
A
,
Fariselli
L
,
Hayashi
M
, et al.
Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: A Systematic Review
.
Neurosurgery
.
2018
Dec
;
83
(
6
):
1128
42
.
[PubMed]
0148-396X
109.
Faramand
A
,
Kano
H
,
Niranjan
A
,
Park
KJ
,
Flickinger
JC
,
Lunsford
LD
.
Tumor Control and Cranial Nerve Outcomes After Adjuvant Radiosurgery for Low-Grade Skull Base Meningiomas
.
World Neurosurg
.
2019
Jul
;
127
:
e221
9
.
[PubMed]
1878-8750
110.
Park
KJ
,
Kano
H
,
Iyer
A
,
Liu
X
,
Tonetti
DA
,
Lehocky
C
, et al.
Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients
.
J Neurosurg
.
2018
Jul
;
•••
:
1
10
.
[PubMed]
1933-0693
111.
Leavitt
JA
,
Stafford
SL
,
Link
MJ
,
Pollock
BE
.
Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery
.
Int J Radiat Oncol Biol Phys
.
2013
Nov
;
87
(
3
):
524
7
.
[PubMed]
0360-3016
112.
Graillon
T
,
Sanson
M
,
Campello
C
,
Idbaih
A
,
Peyre
M
,
Peyrière
H
, et al.
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
.
Clin Cancer Res
.
2020
Feb
;
26
(
3
):
552
7
.
[PubMed]
1078-0432
113.
Kaley
TJ
,
Wen
P
,
Schiff
D
,
Ligon
K
,
Haidar
S
,
Karimi
S
, et al.
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
.
Neuro-oncol
.
2015
Jan
;
17
(
1
):
116
21
.
[PubMed]
1522-8517
114.
Nayak
L
,
Iwamoto
FM
,
Rudnick
JD
,
Norden
AD
,
Lee
EQ
,
Drappatz
J
, et al.
Atypical and anaplastic meningiomas treated with bevacizumab
.
J Neurooncol
.
2012
Aug
;
109
(
1
):
187
93
.
[PubMed]
0167-594X
115.
Schulz
C
,
Mathieu
R
,
Kunz
U
,
Mauer
UM
.
Treatment of unresectable skull base meningiomas with somatostatin analogs
.
Neurosurg Focus
.
2011
May
;
30
(
5
):
E11
.
[PubMed]
1092-0684
116.
Weller
M
,
Roth
P
,
Sahm
F
,
Burghardt
I
,
Schuknecht
B
,
Rushing
EJ
, et al.
Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363
.
J Natl Cancer Inst
.
2017
Mar
;
109
(
3
):
1
4
.
[PubMed]
0027-8874
117.
Dunn
IF
,
Du
Z
,
Touat
M
,
Sisti
MB
,
Wen
PY
,
Umeton
R
, et al.
Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. JCO Precis Oncol.
2018
;2018.
118.
Bi
WL
,
Prabhu
VC
,
Dunn
IF
.
High-grade meningiomas: biology and implications
.
Neurosurg Focus
.
2018
Apr
;
44
(
4
):
E2
.
[PubMed]
1092-0684
119.
Bi
WL
,
Wu
WW
,
Santagata
S
,
Reardon
DA
,
Dunn
IF
.
Checkpoint inhibition in meningiomas
.
Immunotherapy
.
2016
Jun
;
8
(
6
):
721
31
.
[PubMed]
1750-743X
120.
Seystahl
K
,
Stoecklein
V
,
Schüller
U
,
Rushing
E
,
Nicolas
G
,
Schäfer
N
, et al.
Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake
.
Neuro-oncol
.
2016
Nov
;
18
(
11
):
1538
47
.
[PubMed]
1522-8517
121.
Gerster-Gilliéron
K
,
Forrer
F
,
Maecke
H
,
Mueller-Brand
J
,
Merlo
A
,
Cordier
D
.
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
.
J Nucl Med
.
2015
Nov
;
56
(
11
):
1748
51
.
[PubMed]
0161-5505
122.
Marincek
N
,
Radojewski
P
,
Dumont
RA
,
Brunner
P
,
Müller-Brand
J
,
Maecke
HR
, et al.
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial
.
J Nucl Med
.
2015
Feb
;
56
(
2
):
171
6
.
[PubMed]
0161-5505
123.
Bartolomei
M
,
Bodei
L
,
De Cicco
C
,
Grana
CM
,
Cremonesi
M
,
Botteri
E
, et al.
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma
.
Eur J Nucl Med Mol Imaging
.
2009
Sep
;
36
(
9
):
1407
16
.
[PubMed]
1619-7070
124.
van Essen
M
,
Krenning
EP
,
Kooij
PP
,
Bakker
WH
,
Feelders
RA
,
de Herder
WW
, et al.
Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma
.
J Nucl Med
.
2006
Oct
;
47
(
10
):
1599
606
.
[PubMed]
0161-5505
125.
Guedj
E
,
Graillon
T
,
Chinot
O
,
Taieb
D
.
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
.
Eur J Nucl Med Mol Imaging
.
2019
Mar
;
46
(
3
):
537
8
.
[PubMed]
1619-7070
126.
Bernat
AL
,
Oyama
K
,
Hamdi
S
,
Mandonnet
E
,
Vexiau
D
,
Pocard
M
, et al.
Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients
.
Acta Neurochir (Wien)
.
2015
Oct
;
157
(
10
):
1741
6
.
[PubMed]
0001-6268
127.
Peyre
M
,
Gaillard
S
,
de Marcellus
C
,
Giry
M
,
Bielle
F
,
Villa
C
, et al.
Progestin-associated shift of meningioma mutational landscape
.
Ann Oncol
.
2018
Mar
;
29
(
3
):
681
6
.
[PubMed]
0923-7534
128.
Kanaan
I
,
Jallu
A
,
Kanaan
H
.
Management Strategy for Meningioma in Pregnancy: A Clinical Study
.
Skull Base
.
2003
Nov
;
13
(
4
):
197
203
.
[PubMed]
1531-5010
129.
Laviv
Y
,
Bayoumi
A
,
Mahadevan
A
,
Young
B
,
Boone
M
,
Kasper
EM
.
Meningiomas in pregnancy: timing of surgery and clinical outcomes as observed in 104 cases and establishment of a best management strategy
.
Acta Neurochir (Wien)
.
2018
Aug
;
160
(
8
):
1521
9
.
[PubMed]
0001-6268
130.
Lusis
EA
,
Scheithauer
BW
,
Yachnis
AT
,
Fischer
BR
,
Chicoine
MR
,
Paulus
W
, et al.
Meningiomas in pregnancy: a clinicopathologic study of 17 cases
.
Neurosurgery
.
2012
Nov
;
71
(
5
):
951
61
.
[PubMed]
0148-396X
131.
Moscovici
S
,
Fraifeld
S
,
Cohen
JE
,
Dotan
S
,
Elchalal
U
,
Shoshan
Y
, et al.
Parasellar meningiomas in pregnancy: surgical results and visual outcomes
.
World Neurosurg
.
2014
Sep-Oct
;
82
(
3-4
):
e503
12
.
[PubMed]
1878-8750
132.
Chacko
JG
,
Miller
JL
,
Angtuaco
EJ
.
Spontaneous postpartum resolution of vision loss caused by a progesterone receptor-positive tuberculum sellae meningioma
.
J Neuroophthalmol
.
2010
Jun
;
30
(
2
):
132
4
.
[PubMed]
1070-8022
133.
Kerschbaumer
J
,
Freyschlag
CF
,
Stockhammer
G
,
Taucher
S
,
Maier
H
,
Thomé
C
, et al.
Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report
.
J Neurosurg
.
2016
Jan
;
124
(
1
):
137
40
.
[PubMed]
0022-3085
134.
Smith
JS
,
Quiñones-Hinojosa
A
,
Harmon-Smith
M
,
Bollen
AW
,
McDermott
MW
.
Sex steroid and growth factor profile of a meningioma associated with pregnancy
.
Can J Neurol Sci
.
2005
Feb
;
32
(
1
):
122
7
.
[PubMed]
0317-1671
135.
Graillon
T
,
Cuny
T
,
Castinetti
F
,
Courbiere
B
,
Cousin
M
,
Albarel
F
, et al.
Surgical indications for pituitary tumors during pregnancy: a literature review
.
Pituitary
.
2019
Nov
.
[PubMed]
1386-341X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.